BROWSE·page 71 of 141

Browse EX-10 agreements

1,682 matching material contract exhibits.


TRIPLE NET LEASE AGREEMENT

THIS TRIPLE NET LEASE AGREEMENT (the "Lease") is made and entered into this 31st day of July, 2026, by and between SONYA SILVERSTEIN ROTHSTEIN, JULIE M. ROTHSTEIN, AMY L. ROTHSTEIN and SUSAN H. ROTHSTEIN-YOUAKIM, as Co-Trustees of the SONYA S. ROTHSTEIN TRUST under agreement dated 30 July, 2025 ("Lessor") and IONETIX RADIOISOTOPES, INC. (formerly known as IONETIX CORPORATION), a Delaware corporation, with offices at 3130 Sovereign Drive, Lansing, Michigan 48911 ("Lessee").

ARTICLE 1. DEFINITIONS

For purposes of this Lease:

● **1.01 Base Rent. **The "Base Rent" shall be as specified in Section 4.01.
● **1.02 Commencement Date. **The "Commencement Date" is August 1, 2026.

…

EX-10.26·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

TR-FLEX CYCLOTRON SYSTEM SUPPLY CONTRACT

This TR-Flex Cyclotron System Supply Contract (this “Contract” or “Agreement”) is executed as of June 9, 2024, between:

Buyer: Ionetix Corporation
Address: Headquarters: [***] Ship To: [***]
Seller: Advanced Cyclotron Systems Inc.
Address: [***]

…

EX-10.19·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

IONETIX CORPORATION

April 1, 2026

Ionetix Corporation
3130 Sovereign Drive
Lansing, MI 48911

United States

Re: EMPLOYMENT AGREEMENT

Dear Phieu Phun:

On behalf of Ionetix Corporation, a Delaware corporation (the “Company”), I am pleased to offer you the position of Chief Financial Officer of the Company. Your employment by the Company shall be governed by the following terms and conditions (this “Agreement”):

1. Duties and Scope of Employment.

(a) Position. For the term of your employment under this Agreement (your “Employment”), the Company agrees to employ you in the position of Chief Financial Officer. You will report to the Company’s CEO. You will perform the duties and have the responsibilities and authority customarily performed and held by an employee in your position or as otherwise may be assigned or delegated to you by the Company’s CEO.

…

EX-10.18·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

EXECUTION

SIXTH AMENDMENT TO CREDIT AGREEMENT

THIS SIXTH AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into and effective as of November 20, 2025 (“Sixth Amendment Effective Date”) by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), IONETIX ALPHA CORPORATION, a Delaware corporation (“Guarantor”, and together with the borrower, the “Loan Parties”), the Lenders (as defined in the Credit Agreement (as defined herein)), SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”) for the Lenders (Administrative Agent and Collateral Agent, collectively referred to herein as “Agents” and individually, each as an “Agent”).

W I T N E S S E T H:

…

EX-10.15·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

** **

Commercial Lease Agreement

** **

This Commercial Lease Agreement (“Lease”) is made and effective February 1, 2021 (the “Effective Date”) between 6424 Westland, LLC, a Delaware limited liability company (“Landlord”) with an address at c/o Shamrock Holdings, Inc., Attention: Christopher J. Milton, 3500 West Olive Ave., Suite 700, Burbank CA 91505 and Ionetix Corporation, with an address at 101 The Embarcadero, Suite 210, San Francisco, CA 94105 (“Tenant”).

…

EX-10.22·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

** **

FOURTH AMENDMENT TO CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into as of February 20, 2025 (“Fourth Amendment Effective Date”) by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), IONETIX ALPHA CORPORATION, a Delaware corporation (“Guarantor”, and together with the borrower, the “Loan Parties”), the Lenders (as defined in the Credit Agreement (as defined herein)), SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”) for the Lenders (Administrative Agent and Collateral Agent, collectively referred to herein as “Agents” and individually, each as an “Agent”).

W I T N E S S E T H:

…

EX-10.13·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

***SECOND ***AMENDMENT TO CREDIT AGREEMENT

THIS SECOND AMENDMENT TO CREDIT AGREEMENT (“Agreement”) is entered into as of July 18, 2024 by and among IONETIX CORPORATION, a Delaware corporation (“Borrower”), IONETIX ALPHA CORPORATION, a Delaware corporation (“Guarantor”, and together with the Borrower, the “Loan Parties”), the Lenders (as defined in the Credit Agreement (as defined herein)), and SHAMROCK IONETIX, LLC, as administrative agent (“Administrative Agent”) and as collateral agent (“Collateral Agent”) for the Lenders and, solely for purposes of Section 5, the Warrant Investors.

W I T N E S S E T H:

…

EX-10.11·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

IONETIX CORPORATION

April 1, 2026

Ionetix Corporation
3130 Sovereign Drive
Lansing, MI 48911

United States

Re: EMPLOYMENT AGREEMENT

Dear Kevin Cameron:

On behalf of Ionetix Corporation, a Delaware corporation (the “Company”), I am pleased to offer you the position of President and Chief Executive Officer of the Company. Your employment by the Company shall be governed by the following terms and conditions (this “Agreement”):

1. Duties and Scope of Employment.

(a) Position. For the term of your employment under this Agreement (your “Employment”), the Company agrees to employ you in the position of President and Chief Executive Officer. You will report to the Company’s Board of Directors. You will perform the duties and have the responsibilities and authority customarily performed and held by an employee in your position or as otherwise may be assigned or delegated to you by the Company’s Board of Directors.

…

EX-10.17·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

UPMC

UPMC Supply Chain Management - Clinical Capital Agreement

THIS AGREEMENT (the “Agreement”), entered into as of April 11, 2019 between Ionetix Corporation with its principal office at 101 The Embarcadero, Suite 210, San Francisco, CA 94105 (Supplier) and UPMC, with its principal office located at US Steel Tower, 59th Floor, 600 Grant Street, Pittsburgh, Pennsylvania 15219 (“UPMC”).

WHEREAS, Supplier has offered to provide Products and Services to UPMC and to UPMC’s present and future Affiliates; and

WHEREAS, Supplier and UPMC now wish to enter into a written agreement setting forth the terms and conditions for the purchase of the Products and Services.

NOW, THEREFORE, in consideration of the premises and mutual promises contained herein, and intending to be legally bound UPMC and Supplier agree as follows:

…

EX-10.21·S-1·CIK 2108121·ACC 0001213900-26-086823·Filed Aug 07, 2026, 17:31 ET

EXHIBIT 10.2

Danneskjold & Galt Acquisition Co

** **

**INVESTMENT MANAGEMENT TRUST AGREEMENT **

This Investment Management Trust Agreement (this “Agreement”) is made effective as of [_____], 2026 by and between Danneskjold and Galt Acquisition Company, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

WHEREAS, the Company’s registration statement on Form S-1, (File No. 333-[_______]) (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

…

EX-10.2·S-1·CIK 2088286·ACC 0001185185-26-003333·Filed Aug 07, 2026, 16:22 ET

EXHIBIT 10.5

Danneskjold & Galt Acquisition Co

** **

**PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT **

This PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT (this “Agreement”) is made as of [ ], 2026, by and between Danneskjold and Galt Acquisition Company, a Cayman Islands exempted company (the “Company”) and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC ( “CCM” or the “Subscriber”).

WHEREAS, the Company intends to consummate an initial public offering (the “IPO”) of the Company’s units (the “Units”), each Unit consisting of one Class A ordinary share, par value $0.0001 per share (the “Class A Ordinary Shares”), of the Company, and one-half of one redeemable warrant (a “Public Warrant”) to be governed by the Warrant Agreement to be entered into between the Company and Continental stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”). Each whole Warrant entitles the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per Class A Ordinary Share;

…

EX-10.5·S-1·CIK 2088286·ACC 0001185185-26-003333·Filed Aug 07, 2026, 16:22 ET

EXHIBIT 10.8

Danneskjold & Galt Acquisition Co

** **

DANNESKJOLD AND GALT ACQUISITION COMPANY

15 Zephyr

Irvine, CA 92602

September 16, 2025

Atlas Sponsor LLC

15 Zephyr

Irvine, CA 92602

RE: Securities Subscription Agreement

Ladies and Gentlemen:

Danneskjold and Galt Acquisition Company, a Cayman Islands exempted company (the “Company”), is pleased to accept the offer Atlas Sponsor LLC, a Delaware limited liability company, (the “Subscriber” or “you”) has made to subscribe for 7,666,667 Class B ordinary shares of the Company (the “Shares”), US$0.0001 par value per share (the “Class B Ordinary Shares”), up to 1,000,000 of which are subject to complete or partial forfeiture by you if the underwriters of the Company’s initial public offering (“IPO”) of units (“Units”) do not fully exercise their over-allotment option (the “Over-allotment Option”). For the purposes of this Agreement, references to “Ordinary Shares” are to, collectively, the Class B Ordinary Shares and the Company’s Class

…

EX-10.8·S-1·CIK 2088286·ACC 0001185185-26-003333·Filed Aug 07, 2026, 16:22 ET